GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » EV-to-EBIT

Icon (ICLR) EV-to-EBIT : 19.15 (As of Dec. 15, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Icon EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Icon's Enterprise Value is $20,067 Mil. Icon's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $1,048 Mil. Therefore, Icon's EV-to-EBIT for today is 19.15.

The historical rank and industry rank for Icon's EV-to-EBIT or its related term are showing as below:

ICLR' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.58   Med: 20.62   Max: 105.31
Current: 19.15

During the past 13 years, the highest EV-to-EBIT of Icon was 105.31. The lowest was 12.58. And the median was 20.62.

ICLR's EV-to-EBIT is ranked better than
53.85% of 104 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.155 vs ICLR: 19.15

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Icon's Enterprise Value for the quarter that ended in Sep. 2024 was $26,602 Mil. Icon's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $1,048 Mil. Icon's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 3.94%.


Icon EV-to-EBIT Historical Data

The historical data trend for Icon's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon EV-to-EBIT Chart

Icon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.70 25.05 103.79 26.27 28.77

Icon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.49 28.77 30.87 28.31 25.38

Competitive Comparison of Icon's EV-to-EBIT

For the Diagnostics & Research subindustry, Icon's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icon's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Icon's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Icon's EV-to-EBIT falls into.



Icon EV-to-EBIT Calculation

Icon's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=20067.069/1047.997
=19.15

Icon's current Enterprise Value is $20,067 Mil.
Icon's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,048 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icon  (NAS:ICLR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Icon's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) =EBIT / Enterprise Value (Q: Sep. 2024 )
=1047.997/26602.478214
=3.94 %

Icon's Enterprise Value for the quarter that ended in Sep. 2024 was $26,602 Mil.
Icon's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,048 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Icon EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Icon's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Icon Business Description

Traded in Other Exchanges
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.